AVALON INVESTMENT & ADVISORY Corcept Therapeutics Incorporated Transaction History

AVALON INVESTMENT & ADVISORY portfolio value:

$2.77M
portfolio value

AVALON INVESTMENT & ADVISORY quarter portfolio value change:

+7.82%
quarter

Corcept Therapeutics Incorporated 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -6.12% -7.05K shares 33K $25.64 108.12K
Q2 2022 share Increase 0.00% 115.17K shares 2.73M $23.78 115.17K